Market Size of Global Softgel Capsules Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.70 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Softgel Capsules Market Analysis
The Softgel Capsules Market is projected to register a CAGR of 7.7% during the forecast period (2022-2027).
The COVID-19 pandemic had a significant impact on the studied market. Softgel capsules for the treatment of COVID-19 have undergone a number of clinical trials to determine their safety and effectiveness. For instance, the clinical trial of Softgel KOVIR (TD0068) in combination with background treatment in COVID-19 patients was sponsored in October 2021 by Sao Thai Duong Joint Stock Company in association with Vietstar Biomedical Research. The study is evaluating comparative analysis between a standard dose regimen of KOVIR and a placebo combined with background treatment in COVID-19 patients. Similarly, research studies have been conducted on softgel vitamin capsules. For instance, in January 2021, a research study titled "The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design" included a daily dose of oral softgel capsule containing 3200 IU vitamin D3 to be administered daily for 4 weeks. The study stated that softgel vitamin capsules enhanced immunity and will reduce the risk of COVID-19 infection. Hence, the market is expected to grow in the upcoming future.
Factors such as technological development, rising research and development efforts, and increasing consumer demand for products are expected to increase market growth. One of the main drivers of market expansion is the advancement of research and development which increases the capability of the manufacturing of softgels now using a new technology that many businesses have created. For instance, Catalent introduced OptiGel DR technology for the formulation and production of delayed/enteric release softgels in October 2020. Pectin, a naturally occurring polysaccharide, and gelatin are combined in the to create softgel capsules, eliminating need for a separate capsule coating phase. The consequences of stomach reflux can also be reduced by the pills. It enables the softgel capsule shell to incorporate the delayed-release profile, expanding the applications and eliminating the need for a separate capsule coating phase. By doing this, coated softgel quality concerns are potentially eliminated, along with time and yield loss. Furthermore, in November 2020, Roquette launched the LYCAGEL technology, offering a pharmaceutical-grade solution for vegetarian softgel capsule formulations. Such advancements are expected to increase the market share. Hence, the abovementioned factors are expected to increase the market growth over the forecast period.
However, drawbacks associated with softgel capsules are expected to hinder market growth.
Softgel Capsules Industry Segmentation
As per the scope, the softgel capsules are a gelatin-based shell containing a liquid medicament. It is used as a dosage form for a variety of medicines such as vitamins. The Softgel Capsules Market is Segmented By Type (Animal Based and Non-animal Based), Application (Pharmaceutical, Nutraceutical, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Type | |
| Animal Based | |
| Non-animal Based |
| By Application | |
| Pharmaceutical | |
| Nutraceutical | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Softgel Capsules Market Size Summary
The softgel capsules market is poised for significant growth, driven by advancements in technology and increasing consumer demand. The market has been influenced by the COVID-19 pandemic, which spurred clinical trials and research studies involving softgel capsules for treatment and immunity enhancement. Technological innovations, such as Catalent's OptiGel DR technology and Roquette's LYCAGEL technology, have improved the formulation and production processes, expanding the applications of softgel capsules. These developments, along with the benefits of softgel capsules over traditional dosage forms, such as improved bioavailability and safety, are expected to propel market growth. The pharmaceutical industry is witnessing a surge in product launches and expansions, further contributing to the market's expansion.
North America is anticipated to lead the market, supported by increased product approvals and strategic agreements among key players. The region's dominance is bolstered by significant collaborations, such as Catalent's agreement with Aurinia Pharmaceuticals and Strides Pharma's FDA approvals. The market is characterized by partial fragmentation, with major players like Aenova Group, CAPTEK, and Sirio Pharma playing pivotal roles. Recent product launches, such as Windzor Pharma's Solferol Softgel capsules and ZYUS Life Sciences' Zylem Softgel Capsules, highlight the ongoing innovation and competitive landscape. These factors collectively suggest a robust growth trajectory for the softgel capsules market in the coming years.
Global Softgel Capsules Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Technological Advancements and Increasing R&D Activities
-
1.2.2 Growing Demand from Health-conscious Consumers
-
-
1.3 Market Restraints
-
1.3.1 Drawbacks Associated with Softgel Capsules
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Type
-
2.1.1 Animal Based
-
2.1.2 Non-animal Based
-
-
2.2 By Application
-
2.2.1 Pharmaceutical
-
2.2.2 Nutraceutical
-
2.2.3 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Softgel Capsules Market Size FAQs
What is the current Global Softgel Capsules Market size?
The Global Softgel Capsules Market is projected to register a CAGR of 7.70% during the forecast period (2024-2029)
Who are the key players in Global Softgel Capsules Market?
Fuji Capsule Co., Ltd., Sirio Pharma, CAPTEK, United Laboratories and Soft Gel Technologies, Inc. are the major companies operating in the Global Softgel Capsules Market.
